Literature DB >> 10571783

Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis.

I M Bajema1, E C Hagen, J Hermans, L H Noël, R Waldherr, F Ferrario, F J Van Der Woude, J A Bruijn.   

Abstract

BACKGROUND: In kidney biopsies of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis, a variety of histopathological lesions occur, and their relationship to renal outcome is virtually unknown. This multicenter European study reports a clinicopathological analysis of biopsies from 157 patients with systemic vasculitis.
METHODS: The biopsies were evaluated according to a previously standardized scoring protocol. Serum creatinine values were measured at the time of biopsy and one year later. In addition, the lowest creatinine level during follow-up was taken into account as the optimum level of renal function recovery. The clinical prognostic value of the histopathological parameters was analyzed with the Kruskal-Wallis one-way analysis of variance and the Mann-Whitney U-test.
RESULTS: The percentage of normal glomeruli correlated most significantly with renal outcome at all points of measurement (all P < 0.001). Other lesions predicting for renal function were glomerular sclerosis (P < 0.0005 at one year after the biopsy), diffuse interstitial infiltrates (P < 0.0001 at entry, P < 0.0003 at one year), tubular necrosis (P < 0.0025 at entry), and tubular atrophy (P < 0.002 at entry, P < 0.0002 at one year).
CONCLUSION: Traditionally, attention is focused on the extent of active lesions in the renal biopsy in order to determine the severity of renal disease and its implication for renal outcome. Because of their significant impact on renal function, combined with their easy recognition, we recommend the use of the percentage of normal glomeruli in an adequate biopsy in predicting renal function of patients with systemic vasculitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571783     DOI: 10.1046/j.1523-1755.1999.00758.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  58 in total

Review 1.  Clinical management and treatment of vasculitis.

Authors:  D Jayne
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives.

Authors:  Andrea Hinojosa-Azaola; Ariadna Jiménez-González
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

3.  Risk factors for treatment resistance and relapse of Chinese patients with MPO-ANCA-associated vasculitis.

Authors:  Li Huang; Chanjuan Shen; Yong Zhong; Joshua D Ooi; Ya-Ou Zhou; Jin-Biao Chen; Ting Wu; Ting Meng; Zhou Xiao; Wei Lin; Xiang Ao; Xiangcheng Xiao; Qiaoling Zhou; Ping Xiao
Journal:  Clin Exp Med       Date:  2020-02-20       Impact factor: 3.984

4.  IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.

Authors:  Mirjan M van Timmeren; Betty S van der Veen; Coen A Stegeman; Arjen H Petersen; Thomas Hellmark; Mattias Collin; Peter Heeringa
Journal:  J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 10.121

5.  Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.

Authors:  Shen-Ju Gou; Jun Yuan; Chen Wang; Ming-Hui Zhao; Min Chen
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

6.  The expression of Toll-like receptors 2, 4 and 9 in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Authors:  H Wang; S-J Gou; M-H Zhao; M Chen
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

7.  The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood.

Authors:  Damien G Noone; Marinka Twilt; Wesley N Hayes; Paul S Thorner; Susanne Benseler; Ronald M Laxer; Rulan S Parekh; Diane Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 8.237

Review 8.  Pathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis.

Authors:  I M Bajema
Journal:  Clin Exp Immunol       Date:  2011-05       Impact factor: 4.330

9.  Poor renal outcomes in patients with anti-neutrophil cytoplasmic antibody-associated crescentic glomerulonephritis and normal renal function at diagnosis.

Authors:  Hironari Hanaoka; Yuichiro Ota; Tsutomu Takeuchi; Masataka Kuwana
Journal:  Clin Rheumatol       Date:  2016-01-07       Impact factor: 2.980

10.  Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine.

Authors:  Clara J Day; Alec J Howie; Peter Nightingale; Shazia Shabir; Dwomoa Adu; Caroline O Savage; Peter Hewins
Journal:  Am J Kidney Dis       Date:  2009-12-31       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.